Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan
NCT07716189Phase 3Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in nausea ((none)) and Vomiting (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Proportion of patients experiencing nausea at 5 days. Started Dec 2025; status: recruiting.
02
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT07716189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07716189.